scholarly article | Q13442814 |
P50 | author | Eduardo Bruera | Q60386359 |
Mark F Munsell | Q90326364 | ||
P2093 | author name string | Shana Palla | |
Guddi Kaur | |||
Paul W Walker | |||
Karen Zhang | |||
Be-Lian Pei | |||
Jeanine Hanohano | |||
P2860 | cites work | Opioid rotation for cancer pain: rationale and clinical aspects | Q33765787 |
Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing | Q34331439 | ||
Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain | Q34522615 | ||
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine | Q41075101 | ||
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences | Q44348350 | ||
Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study | Q73629700 | ||
Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study | Q74323132 | ||
Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? | Q77435831 | ||
Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain | Q78254638 | ||
P433 | issue | 8 | |
P921 | main subject | opioid | Q427523 |
P304 | page(s) | 1103-1108 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Journal of Palliative Medicine | Q6295711 |
P1476 | title | Switching from methadone to a different opioid: what is the equianalgesic dose ratio? | |
P478 | volume | 11 |
Q38123824 | A review of common methods to convert morphine to methadone |
Q44334284 | A synthesis of oral morphine equivalents (OME) for opioid utilisation studies |
Q41869538 | Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study |
Q36110411 | Equianalgesic doses of opioids - their use in clinical practice |
Q91807667 | Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care |
Q36630474 | Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids |
Q36969714 | Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 Cases |
Q37894995 | Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain? |
Q38792112 | Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit |
Q33612033 | Methadone initiation and rotation in the outpatient setting for patients with cancer pain |
Q53401169 | Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. |
Q38084807 | Palliative care research: lessons learned by our team over the last 25 years |
Q50351829 | Practical Guide for Using Methadone in Pain and Palliative Care Practice. |
Q53589962 | Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study. |
Q36996916 | The McGill University Health Centre Cancer Pain Clinic: A Retrospective Analysis of an Interdisciplinary Approach to Cancer Pain Management |
Q41382878 | The challenge of perioperative pain management in opioid-tolerant patients |
Q34458000 | The opioid rotation ratio of hydrocodone to strong opioids in cancer patients |
Q40449086 | The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients. |
Q39279116 | The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study |
Q44993116 | The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids |
Q34394425 | Toward a systematic approach to opioid rotation |
Q36006860 | Variable Patterns of Continuous Morphine Infusions at End of Life |
Search more.